Gene transfer into vascular cells using adeno-associated virus (AAV) vectors

Cardiovascular Research

Volumn 35, Issue 3, 1997, Pages 514-521

  Maeda, Yoshikazu ^a   Ikeda, Uichi ^a   Ogasawara, Yoji ^a   Urabe, Masashi ^a   Takizawa, Toshihiro ^a   Saito, Takuma ^a   Colosi, Peter ^b   Kurtzman, Gary ^b   Shimada, Kazuyuki ^a   Ozawa, Keiya ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Avigen Inc   (United States)

Author keywords

Adeno associated virus vector; Aorta; Endothelial cell; Gene transfer; Smooth muscle cell

Indexed keywords

VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE TRANSFER; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER;

AORTA, THORACIC; CELLS, CULTURED; DEPENDOVIRUS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LAC OPERON; MUSCLE, SMOOTH, VASCULAR;

EID: 0030778674     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00163-6     Document Type: Article

References (34)

1. Nabel E.G., Plautz G., Nabel G.J. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science. 249:1990;1285-1288.
2. Lynch CM, Clowes MM, Osborne WR, Clowes AW, Miller AD. Long-term expression of human adenosine deaminase in vascular smooth muscle cells of rats: a model for gene therapy. Proc Natl Acad Sci USA 1992;89:1138-1142.
3. Geary R.L., Clowes A.W., Lau S., Vergel S., Dale D.C., Osborne W.R. Gene transfer in baboons using prosthetic vascular grafts seeded with retrovirally transduced smooth muscle cells: a model for local and systemic gene therapy. Hum Gene Ther. 5:1994;1211-1216.
4. Flugelman M.Y., Jaklitsch M.T., Newman K.D., Casscells W., Bratthauer G.L., Dichek D.A. Low level in vivo gene transfer into the arterial wall through a perforated balloon catheter. Circulation. 85:1992;1110-1117.
5. Plautz G., Nabel E.G., Nabel G.J. Introduction of vascular smooth muscle cells expressing recombinant genes in vivo. Circulation. 83:1991;578-583.
6. Clowes M.M., Lynch C.M., Miller A.D., Miller D.G., Osborne W.R., Clowes A.W. Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes. J Clin Invest. 93:1994;644-651.
7. Kahn M.L., Lee S.W., Dichek D.A. Optimization of retroviral vector-mediated gene transfer into endothelial cells in vitro. Circ Res. 71:1992;1508-1517.
8. Yao A., Wang D.H. Heterogeneity of adenovirus mediated gene transfer in cultured thoracic aorta and renal artery of rats. Hypertension. 26(2):1995;1046-1050.
9. Guzman R.J., Lemarchand P., Crystal R.G., Epstein S.E., Finkel T. Efficient and selective adenovirus-mediated gene transfer into vascular neointima. Circulation. 88:1993;2838-2848.
10. Lee S.W., Trapnell B.C., Rade J.J., Virmani R., Dichek D.A. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ Res. 73:1993;797-807.
11. Lemarchand P., Jones M., Yamada I., Crystal R.G. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res. 72:1993;1132-1138.
12. Schulick A.H., Dong G., Newman K.D., Virmani R., Dichek D.A. Endothelium-specific in vivo gene transfer. Circ Res. 77:1995;475-485.
13. Schulick A.H., Newman K.D., Virmani R., Dichek D.A. In vivo gene transfer into injured carotid arteries. Optimization and evaluation of acute toxicity. Circulation. 91:1995;2407-2414.
14. Steg P.G., Feldman L.J., Scoazec J.Y., Tahlil O., Barry J.J., Boulechfar S., Ragot T., Isner J.M., Perricaudet M. Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector. Circulation. 90:1994;1648-1656.
15. Schneider M.D., French B.A. The advent of adenovirus. Gene therapy for cardiovascular disease. Circulation. 88:1993;1937-1942.
16. Willard J.E., Landau C., Glamann D.B., Burns D., Jessen M.E., Pirwitz M.J., Gerard R.D., Meidell R.S. Genetic modification of the vessel wall. Comparison of surgical and catheter-based techniques for delivery of recombinant adenovirus. Circulation. 89:1994;2190-2197.
17. Nabel E.G. Gene therapy for cardiovascular disease. Circulation. 91:1995;541-548.
18. Pickering J.G., Weir L., Jekanowski J., Kearney M., Isner J.M. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest. 91:1993;1469-1480.
19. O'Brien E.R., Alpers C.E., Stewart D.K. Proliferation in primary and restenotic coronary atherectomy tissue. Implication for antiproliferative therapy. Circ Res. 73:1993;223-231.
20. Flotte T.R., Afione S.A., Zeitlin P.L. Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am J Respir Cell Mol Biol. 11:1994;517-521.
21. Podsakoff G., Wong K.K. Jr., Chatterjee S. Efficient gene transfer into nondividing cells by deno-associated virus-based vectors. J Virol. 68:1994;5656-5666.
22. Flotte T.R., Afione S.A., Conrad C., McGrath S.A., Solow R., Oka H., Zeitlin P.L., Guggino W.B., Carter B.J. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci USA. 90:1993;10613-10617.
23. Kaplitt M.G., Leone P., Samulski R.J., Xiao X., Pfaff D.W., O'Malley K.L., During M.J. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet. 8:1994;148-154.
24. Kessler P.D., Podsakoff G.M., Chen X., McQuiston S.A., Colosi P.C., Matelis L.A., Kurtzman G.J., Byrne B.J. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci USA. 93:1996;14082-14087.
25. Okada H., Miyamura K., Itoh T., Hagiwara M., Wakabayashi T., Mizuno M., Colosi P., Kurtzman G., Yoshida J. Gene therapy against an experimental glioma using adeno-associated virus vectors. Gene Ther. 3:1996;957-964.
26. Colosi P, Elliger S, Elliger C, Kurtzman G. AAV vectors can be efficiently produced without helper virus. Blood 1995;627a(abstract).
27. Ikeda U., Ikeda M., Oohara T., Oguchi A., Kamitani T., Tsuruya Y., Kano S. Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol. 260:1991;H1713-H1717.
28. Sanes J.R., Rubenstein J.L.R., Nicolas J.F. Use of recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5:1986;3133-3142.
29. Kotin R.M., Linden R.M., Berns K.I. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 11:1992;5071-5078.
30. Samulski R.J., Zhu X., Xiao X., Brook J.D., Housman D.E., Epstein N., Hunter L.A. Targeted integration of adeno-associated virus (AAV) into human chromosome 19 [published erratum appears in EMBO J 1992 Mar;11(3):1228]. EMBO J. 10:1991;3941-3950.
31. Giraud C., Winocour E., Berns K.I. Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence. Proc Natl Acad Sci USA. 91:1994;10039-10043.
32. Weitzman M.D., Kyostio S.R., Kotin R.M., Owens R.A. Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc Natl Acad Sci USA. 91:1994;5808-5812.
33. Rome J.J., Shayani V., Flugelman M.Y., Newman K.D., Farb A., Virmani R., Dichek D.A. Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall. Modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Arterioscler Thromb. 14:1994;148-161.
34. Russell D.W., Miller A.D., Alexander I.E. Adeno-associated virus vectors preferentially transduce cells in S phase. Proc Natl Acad Sci USA. 91:1994;8915-8919.